NeuroPace (NPCE) Cash from Investing Activities (2020 - 2026)

NeuroPace's (NPCE) quarterly Cash from Investing Activities came in at -$117000.0 in Q1 2026, down 216.22% year-on-year from $100674.4 in Q1 2025, and down 20.62% quarter-over-quarter from -$97000.0 in Q4 2025.

NeuroPace (NPCE) Cash from Investing Activities (2020 - 2026) Analysis & Trends

NeuroPace's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$117000.0 for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 216.22% year-over-year to -$117000.0 in Q1 2026; TTM through Mar 2026 was -$412000.0, a 106.28% decrease from a year earlier, with the FY2025 full-year figure at -$332000.0, down 103.69% from the prior year.
  • Cash from Investing Activities fell to -$117000.0 in Q1 2026 per NPCE's latest filing, from -$97000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $10.1 million in Q1 2023 and bottomed at -$306000.0 in Q1 2022.
  • The 5-year median for Cash from Investing Activities is $2.4 million (2024), against an average of $3.3 million.
  • Across the five-year window, Cash from Investing Activities jumped 5877.92% in 2022 and plunged 216.22% in 2026, its largest moves.
  • Year by year, Cash from Investing Activities stood at $8.9 million in 2022, then tumbled by 61.02% to $3.5 million in 2023, then tumbled by 43.45% to $2.0 million in 2024, then plunged by 104.95% to -$97000.0 in 2025, then retreated by 20.62% to -$117000.0 in 2026.
  • Per Business Quant, the three latest NPCE Cash from Investing Activities figures stand at -$117000.0 (Q1 2026), -$97000.0 (Q4 2025), and -$30000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.13 Bn 175.83 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 108.98 Bn 99.76 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 68.45 Bn 67.00 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.01 Bn 44.34 Bn 1.29 Bn -92.80 Mn
6 GE HealthCare Technologies 28.29 Bn 26.01 Bn 1.98 Bn -2.50 Bn
7 Dexcom 28.25 Bn 27.13 Bn 750.30 Mn -298.50 Mn
8 Smith & Nephew 26.91 Bn 26.33 Bn - -
9 Koninklijke Philips 25.45 Bn 22.32 Bn 2.07 Bn -475.32 Mn
10 NeuroPace 516.20 Mn 462.22 Mn 18.05 Mn -117,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -117,000.00
Mar 31, 2026 -117,000.00
Dec 31, 2025 -97,000.00
Dec 31, 2025 -97,000.00
Sep 30, 2025 -30,000.00
Sep 30, 2025 -30,000.00
Jun 30, 2025 -168,000.00
Jun 30, 2025 -168,000.00
Mar 31, 2025 -37,000.00
Mar 31, 2025 -37,000.00
Dec 31, 2024 1.96 Mn
Dec 31, 2024 1.96 Mn
Sep 30, 2024 1.40 Mn
Sep 30, 2024 1.40 Mn
Jun 30, 2024 3.24 Mn
Jun 30, 2024 3.24 Mn
Mar 31, 2024 2.40 Mn
Mar 31, 2024 2.40 Mn
Dec 31, 2023 3.47 Mn
Dec 31, 2023 3.47 Mn